HRAS and gastric cancer: The results showed that 14 core targets TP53, JUN, CASP3, HSP90AA1, VEGFA, HRAS, CDH1, MAPK3, PPARG, CDKN1A, SRC, CYCS, BCL2L1 and CDK4 were significantly associated with poor prognosis in GC (p < 0.05).